Clinical Trial

Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage

Name: Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage — clinical trial record (NCT07249853)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAPTAIN

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The investigators propose to conduct a multicenter randomized trial to test whether cilostazol reduces the incidence of delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage (aSAH) and improves patients' neurological prognosis, while assessing its safety.

Trial Details

NCT Number	NCT07249853
Lead Sponsor	Beijing Tiantan Hospital
Conditions	Aneurysmal Subarachnoid Hemorrhage
Enrollment	316 participants
Start Date	2025-11-30
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-08-31 (estimated)
Updated on ClinicalTrials.gov	2025-11-25